Allogene Therapeutics Inc (NASDAQ:ALLO)
| 5.01 Delayed Data As of Mar 22 |  -0.32 / -5.97%Today’s Change | 5.00 Today|||52-Week Range 17.49 | -20.35% Year-to-Date |
Latest ALLO News | Press Releases
| Aridis (ARDS) Stock Up as Cystic Fibrosis Study Meets Goals Mar 14 / Zacks.com - Paid Partner Content | BioNTech (BNTX) to Report Q4 Earnings: What's in the Cards? Mar 10 / Zacks.com - Paid Partner Content |
| Reata (RETA) Stock Doubles This Year on Skyclarys FDA Nod Mar 13 / Zacks.com - Paid Partner Content | Vertex (VRTX) to Begin Clinical Study on Type I Diabetes Drug Mar 10 / Zacks.com - Paid Partner Content |
| Roche (RHHBY) Polivy Combo Backed by FDA Advisory Committee Mar 10 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 5.36 |
| Today’s open | 5.33 |
| Day’s range | 5.00 - 5.44 |
| Volume | 2,482,610 |
| Average volume (3 months) | 1,959,924 |
| Market cap | $790.4M |
Data as of 4:00pm ET, 03/22/2023
Growth & Valuation
| Earnings growth (last year) | -22.80% |
| Earnings growth (this year) | -4.61% |
| Earnings growth (next 5 years) | +22.95% |
| Revenue growth (last year) | -99.37% |
| P/E ratio | NM |
| Price/Sales | 3,705.33 |
| Price/Book | 1.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MCRBSeres Therapeutics I... | -0.23 | -3.78% |
| IBRXImmunitybio Inc | -0.22 | -11.68% |
| COGTCogent Biosciences I... | -0.83 | -7.61% |
| ANIPANI Pharmaceuticals ... | -1.09 | -2.74% |
Data as of 4:00pm ET, 03/22/2023
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $243.0K |
| Annual profit (last year) | -$332.6M |
| Net profit margin | -136,885.60% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
